Skip to main content
SpringerLink
Log in

Effects of intra-arterial ketanserin in Raynaud's phenomenon assessed by 99MTc-pertechnetate scintigraphy

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The severity of the peripheral vasopastic condition in 10 patients with Raynaud's phenomenon was investigated using scintigraphy of both hands. 99MTc-pertechnetate was used as a diffusable tracer and scintigrams were recorded with normal hand skin temperature and following immersion of the hands in ice-cold water.

Cold provocation resulted in a marked reduction of the rate of blood inflow and tissue perfusion in affected hands.

The selective peripheral S2-antagonist ketanserin and placebo were administered intra-arterially according to a double-blind cross-over design. As compared to placebo, ketanserin significantly improved the rate of inflow following cold provocation, and it increased tissue perfusion in the hands of the patients to values normally observed in healthy individuals.

The results support the use of ketanserin in the treatment of Raynaud's phenomenon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Editorial (1980) Pathophysiology of Raynaud's phenomenon. Br Med J 281: 1027–1028

  2. Seibold JR (1985) Serotonin and Raynaud's phenomenon. In: Vanhoutte PM (ed) Serotonin and the cardiovascular system. Raven Press, New York

    Google Scholar 

  3. Halpern A, Kuhn PH, Shaftel HE, Samuels SS, Shaftel N, Selman D, Birch HG (1960) Raynaud's disease, Raynaud's phenomenon, and serotonin. Angiology 11: 151–167

    Google Scholar 

  4. Janssen PAJ (1983) 5-HT2-receptor blockade to study serotonin-induced pathology. Trends Pharmacol Sci 4: 198–206

    Google Scholar 

  5. De Cree J, Geukens H, Leempoels J, Verhagen H (1984) Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication. Lancet 2: 775–779

    Google Scholar 

  6. Stranden E, Roald OK, Krohg K (1982) Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin. Br Med J 285: 1069–1071

    Google Scholar 

  7. Roald OK, Seem E (1984) Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders. Br Med J 289: 577–579

    Google Scholar 

  8. Van der Starre PJA, Scheygrond HW, Reneman RS, Kolling JB (1983) The use of ketanserin, a 5-hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery. Anesth Analg 62: 63–69

    Google Scholar 

  9. Wenting GJ, Woittiez AJJ, Man in 't Veld AJ, Schalekamp MADH (1984) 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension 6: 100–109

    Google Scholar 

  10. Gerritsen HA, Kazem I, Hasman A, Kuypers PJ (1974) A new approach to the evaluation of peripheral vascular disease using the gamma camera. Radiology 112: 115–121

    Google Scholar 

  11. Seibold JR, Jageneau AHM (1984) Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2)-receptor. Arthritis Rheum 27: 139–146

    Google Scholar 

  12. Van de Wal HJCM, Wijn PFF, Van Lier HJJ, Skotnicki SH (1985) Quantitative study of the effects of ketanserin in patients with primary Raynaud's phenomenon. Microcirc Endothelium Lymphatics 2: 657–685

    Google Scholar 

  13. Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R 41468, a novel antagonist at 5-HT2-receptors. Life Sci 28: 1015–1022

    Google Scholar 

  14. Hechtman DH, Jageneau A (1985) Inhibition of cold-induced vasoconstriction with ketanserin. Microvasc Res 30: 56–62

    Google Scholar 

  15. Van Nueten JM, Janssen PAJ, De Ridder W, Vanhoutte PM (1982) Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit: Effect of ketanserin (R 41468). Eur J Pharmacol 77: 281–287

    Google Scholar 

  16. Van Nueten JM, De Ridder W, Vanhoutte PM (1984) Ketanserin and vascular contractions in response to cooling. Eur J Pharmacol 99: 329–332

    Google Scholar 

  17. De Clerck F, David JL, Janssen PAJ (1982) Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R41468), a selective 5-HT2-receptor antagonist. Agents Actions 12: 388–397

    Google Scholar 

  18. Nielsen SL, Vitting K, Rasmussen K (1983) Prazosin treatment of primary Raynaud's phenomenon. Eur J Clin Pharmacol 24: 424–423

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anaesthesiology, Bethesda Hospital, Hoogeveen, The Netherlands

    J. J. Kunnen

  2. Department of Vascular Surgery, Bethesda Hospital, Hoogeveen, The Netherlands

    H. P. Dahler

  3. Laboratory of Nuclear Medicine, Group of Cooperating Hospitals in the Northeast Netherlands, The Netherlands

    J. G. Doorenspleet

  4. Janssen Pharmaceutica B. V., Goirle, The Netherlands

    J. C. van Oene

Authors
  1. J. J. Kunnen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. P. Dahler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. G. Doorenspleet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. C. van Oene
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kunnen, J.J., Dahler, H.P., Doorenspleet, J.G. et al. Effects of intra-arterial ketanserin in Raynaud's phenomenon assessed by 99MTc-pertechnetate scintigraphy. Eur J Clin Pharmacol 34, 267–271 (1988). https://doi.org/10.1007/BF00540954

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00540954

Key words

Search

Navigation